NYLIM
IART icon

New York Life Investment Management’s Integra LifeSciences IART Stock Holding History

New York Life Investment Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,565
Closed -$375K – 1079
2024
Q1 		$375K Buy
+10,565
New +$423K ﹤0.01% 896

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

New York Life Investment Management's IART Position: Q2 2024 in Review

New York Life Investment Management sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 10,565 shares — an estimated $375K sold.

New York Life Investment Management first reported a position in IART in Q1 2024 and held it in 1 quarter. The position peaked at $375K in Q1 2024. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.

  • New York Life Investment Management reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 10,565 Integra LifeSciences shares in Q2 2024, an estimated $375K.
  • New York Life Investment Management first reported a position in Integra LifeSciences in Q1 2024 and held it in 1 quarter.
  • New York Life Investment Management's Integra LifeSciences position peaked at $375K in Q1 2024.
  • 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.